NO20071326L - Kondenserte trisykliske derivater for behandling av psykotiske forstyrrelser - Google Patents
Kondenserte trisykliske derivater for behandling av psykotiske forstyrrelserInfo
- Publication number
- NO20071326L NO20071326L NO20071326A NO20071326A NO20071326L NO 20071326 L NO20071326 L NO 20071326L NO 20071326 A NO20071326 A NO 20071326A NO 20071326 A NO20071326 A NO 20071326A NO 20071326 L NO20071326 L NO 20071326L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- psychotic disorders
- tricyclic derivatives
- condensed tricyclic
- condensed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0419315A GB0419315D0 (en) | 2004-08-31 | 2004-08-31 | Compounds |
GB0507386A GB0507386D0 (en) | 2005-04-12 | 2005-04-12 | Compounds |
GB0515010A GB0515010D0 (en) | 2005-07-21 | 2005-07-21 | Compounds |
PCT/EP2005/009379 WO2006024517A1 (en) | 2004-08-31 | 2005-08-29 | Fused tricyclic derivatives for the treatment of psychotic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20071326L true NO20071326L (no) | 2007-05-03 |
Family
ID=35106764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20071326A NO20071326L (no) | 2004-08-31 | 2007-03-12 | Kondenserte trisykliske derivater for behandling av psykotiske forstyrrelser |
Country Status (17)
Country | Link |
---|---|
US (1) | US20120022056A1 (no) |
EP (1) | EP1786822A1 (no) |
JP (1) | JP2008511574A (no) |
KR (1) | KR20070057885A (no) |
CN (1) | CN101048414B (no) |
AR (1) | AR053307A1 (no) |
AU (1) | AU2005279278A1 (no) |
BR (1) | BRPI0514377A (no) |
CA (1) | CA2578781A1 (no) |
IL (1) | IL181387A (no) |
MA (1) | MA28871B1 (no) |
MX (1) | MX2007002548A (no) |
NO (1) | NO20071326L (no) |
NZ (1) | NZ553506A (no) |
PE (1) | PE20060653A1 (no) |
TW (1) | TW200619221A (no) |
WO (1) | WO2006024517A1 (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0316915D0 (en) | 2003-07-18 | 2003-08-20 | Glaxo Group Ltd | Compounds |
US7898642B2 (en) | 2004-04-14 | 2011-03-01 | Asml Netherlands B.V. | Lithographic apparatus and device manufacturing method |
BRPI0615248A2 (pt) * | 2005-08-26 | 2009-07-14 | Shionogi & Co | derivado tendo atividade agonista de ppar |
EP1978966A4 (en) * | 2006-01-23 | 2010-11-10 | Amira Pharmaceuticals Inc | TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE |
US7501438B2 (en) | 2006-07-07 | 2009-03-10 | Forest Laboratories Holdings Limited | Pyridoimidazole derivatives |
US7544833B2 (en) | 2006-09-07 | 2009-06-09 | Hoffmann-La Roche Inc. | Methods for producing N-(8-[2-hydroxybenzoyl]-amino) caprylic acid |
JP2010504367A (ja) | 2006-09-26 | 2010-02-12 | グラクソ グループ リミテッド | 性機能障害、認知障害、精神病性障害、不安、鬱病などを処置するための5ht1a受容体モジュレーターとしての5−{2−[4−(2−メチル−5−キノリニル)−l−ピペリジニル]エチル}キノリノン誘導体 |
CA2680312A1 (en) * | 2007-03-07 | 2008-09-12 | Alantos Pharmaceuticals Holding, Inc. | Metalloprotease inhibitors containing a heterocyclic moiety |
EP2070933A1 (en) * | 2007-12-07 | 2009-06-17 | Laboratorios del Dr. Esteve S.A. | Tricyclic triazolic compounds |
GB0800840D0 (en) | 2008-01-17 | 2008-02-27 | Glaxo Group Ltd | Novel salt |
EP2268644B1 (en) | 2008-03-05 | 2011-08-17 | Boehringer Ingelheim International GmbH | Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
US8669249B2 (en) * | 2009-03-27 | 2014-03-11 | Takeda Pharmaceutical Company Limited | Poly (ADP-ribose) polymerase (PARP) inhibitors |
EA201201160A1 (ru) | 2010-02-19 | 2013-04-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Трициклические производные пиридина, лекарственные средства, содержащие такие соединения, их применение и способ их получения |
KR20130087002A (ko) | 2010-06-04 | 2013-08-05 | 알바니 몰레큘라 리써치, 인크. | 글리신 수송체-1 저해제, 그의 제조 방법 및 그의 용도 |
WO2012154731A1 (en) * | 2011-05-08 | 2012-11-15 | Vanderbilt University | Substituted 1h-pyrrolo[3,2-c]quinolin-4(5h)-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
WO2013024130A1 (en) | 2011-08-17 | 2013-02-21 | Boehringer Ingelheim International Gmbh | Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation |
EP2792679A1 (en) * | 2013-04-19 | 2014-10-22 | Laboratorios Del. Dr. Esteve, S.A. | Tricyclic triazolic compounds |
EP3013823B1 (en) * | 2013-06-24 | 2017-11-01 | Merck Patent GmbH | Imidazole compounds as modulators of fshr and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9706196A (es) * | 1996-08-14 | 1998-02-28 | Pfizer | Compuestos triciclicos de piperidinilamino como antagonistas de la sustancia p. |
IL124914A (en) * | 1997-06-26 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical compositions containing 6-aryl-2,3,5,6-tetrahydroimidazo¬2,1-a¾isoquinoline derivatives and some new such compounds |
US6919334B2 (en) * | 2002-09-12 | 2005-07-19 | Wyeth | Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine |
GB0227240D0 (en) * | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
-
2005
- 2005-08-26 PE PE2005000983A patent/PE20060653A1/es not_active Application Discontinuation
- 2005-08-29 TW TW094129416A patent/TW200619221A/zh unknown
- 2005-08-29 NZ NZ553506A patent/NZ553506A/en not_active IP Right Cessation
- 2005-08-29 CA CA002578781A patent/CA2578781A1/en not_active Abandoned
- 2005-08-29 WO PCT/EP2005/009379 patent/WO2006024517A1/en active Application Filing
- 2005-08-29 EP EP05778196A patent/EP1786822A1/en not_active Withdrawn
- 2005-08-29 JP JP2007528777A patent/JP2008511574A/ja active Pending
- 2005-08-29 CN CN2005800372427A patent/CN101048414B/zh not_active Expired - Fee Related
- 2005-08-29 AR ARP050103607A patent/AR053307A1/es not_active Application Discontinuation
- 2005-08-29 KR KR1020077007190A patent/KR20070057885A/ko not_active Application Discontinuation
- 2005-08-29 AU AU2005279278A patent/AU2005279278A1/en not_active Abandoned
- 2005-08-29 BR BRPI0514377-2A patent/BRPI0514377A/pt not_active IP Right Cessation
- 2005-08-29 MX MX2007002548A patent/MX2007002548A/es active IP Right Grant
- 2005-08-29 US US11/574,450 patent/US20120022056A1/en not_active Abandoned
-
2007
- 2007-02-15 IL IL181387A patent/IL181387A/en not_active IP Right Cessation
- 2007-03-12 NO NO20071326A patent/NO20071326L/no not_active Application Discontinuation
- 2007-03-23 MA MA29771A patent/MA28871B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
JP2008511574A (ja) | 2008-04-17 |
WO2006024517A1 (en) | 2006-03-09 |
IL181387A (en) | 2011-10-31 |
CN101048414B (zh) | 2011-09-07 |
MX2007002548A (es) | 2007-04-24 |
EP1786822A1 (en) | 2007-05-23 |
MA28871B1 (fr) | 2007-09-03 |
KR20070057885A (ko) | 2007-06-07 |
NZ553506A (en) | 2010-02-26 |
PE20060653A1 (es) | 2006-09-27 |
US20120022056A1 (en) | 2012-01-26 |
BRPI0514377A (pt) | 2008-06-24 |
AR053307A1 (es) | 2007-05-02 |
AU2005279278A1 (en) | 2006-03-09 |
CA2578781A1 (en) | 2006-03-09 |
CN101048414A (zh) | 2007-10-03 |
TW200619221A (en) | 2006-06-16 |
IL181387A0 (en) | 2007-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20071326L (no) | Kondenserte trisykliske derivater for behandling av psykotiske forstyrrelser | |
CY2018028I1 (el) | Βενζοθειοφαινια υποκατεστημενα με πιπεραζινη για την αγωγη διανοητικων διαταραχων | |
DK1474416T3 (da) | Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser | |
DK1572215T3 (da) | Benzo[D]azepin-derivater til behandling af neurologiske lidelser | |
NO20070753L (no) | Fremgangsmåte for fremstilling av dihydropteridinoner | |
ZA200801888B (en) | Derivatives of 4-piperazin-1-1-YL-4-benzo [B] thiophene suitable for the treatment of CNS disorders | |
CY2013022I1 (el) | Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων | |
CY2015024I2 (el) | Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων | |
DK1708992T3 (da) | Sulfonamidderivater til behandling af sygdomme | |
ZA200706791B (en) | Isoxazole combretasin derivatives for the treatment of disorders | |
IL180736A0 (en) | Hydantoin derivatives for the treatment of inflammatory disorders | |
IL180680A0 (en) | Piperazine derivatives useful for the treatment of gastrointestinal disorders | |
NO20053211D0 (no) | Forbindelser for behandling av metabolske forstyrrelser. | |
NO20055588D0 (no) | Pyrimidinderivater anvendelige for behandling av sykdommer mediert av CRTH2 | |
NO20052223D0 (no) | Tiazolforbindelser for behandling av neurodegenerative forstyrrelser | |
NO20055098D0 (no) | Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser | |
DK1847524T3 (da) | Terphenylderivater til behandling af Alzheimers sygdom | |
DK1907374T3 (da) | Til behandling af gastrointestinale sygdomme anvendelige benzylpiperazin-derivater | |
DK1841433T3 (da) | Præparat til behandling af lidelser i centralnervesystemet | |
NO20082458L (no) | Fremgangsmåter for fremstilling av cyklopropyl-amidderivat | |
ATE448228T1 (de) | Pyrrolopyrimidinderivate zur behandlung proliferativer krankheiten | |
DK1940447T3 (da) | Behandling af neurodegenrative lidelser | |
ATE446757T1 (de) | 1-ä2h-1-benzopyran-2-one-8-ylü- piperazinderivative zur behandlung von bewegungsstörungen | |
IS8225A (is) | 2-etoxý-3-fenýlprópíónsýruafleiður til að meðhöndla fitusjúkdóma | |
DE602004011679D1 (de) | Behandelung von Störungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |